HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ALX Oncology Holdings (NASDAQ:ALXO) with a Buy and maintains $25 price target.
- Headlines
- HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $25 Price Target
HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $25 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
06:59
Huatai Research has given a buy initiation rating to Suton Ju Chuang Technology Co., Ltd.
ROBOSENSE+5.48%
06:54
The Security Council is concerned about the attacks on hospitals in northern Gaza, and China calls for all necessary actions to achieve a ceasefire.
06:52
The elected vice president of the USA, Vance, underwent a minor sinus surgery and will return to work on January 4.